EP2264028 - Pyrazole compounds useful as protein kinase inhibitors [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 04.12.2015 Database last updated on 31.08.2024 | Most recent event Tooltip | 04.12.2015 | Application deemed to be withdrawn | published on 06.01.2016 [2016/01] | Applicant(s) | For all designated states Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston, MA 02210 / US | [2014/35] |
Former [2014/09] | For all designated states Vertex Pharmaceuticals Inc. 50 Northern Avenue Boston, MA 02210 / US | ||
Former [2010/51] | For all designated states VERTEX PHARMACEUTICALS INCORPORATED 130 Waverly Street Cambridge, MA 02139-4242 / US | Inventor(s) | 01 /
Bebbington, David 6 Linden Close Newbury, Berkshire RG1 4QA / GB | 02 /
Charrier, Jean-Damien Vertex Pharma. Inc Cottage Wing Station Rd Southa Bishops Itchington, Oxfordshire CV47 2QB / GB | 03 /
Golec, Julian 8 Manor Farm Chapel Road Ashbury, Wiltshire SN6 8LS / GB | 04 /
Miller, Andrew Cherry Cottage Chilton Road Upton Didcot, Oxfordshire OX11 9JL / GB | 05 /
Knegtel, Ronald 3 Bath Court Bath Street Abingdon, Oxfordshire OX11 1EE / GB | [2010/51] | Representative(s) | Coles, Andrea Birgit, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [N/P] |
Former [2011/31] | Coles, Andrea Birgit, et al Kilburn & Strode LLP 20 Red Lion Street London WC1R 4PJ / GB | ||
Former [2010/51] | Coles, Andrea Birgit Kilburn & Strode LLP 20 Red Lion Street London WC1R 4PJ / GB | Application number, filing date | 10184271.4 | 19.12.2001 | [2010/51] | Priority number, date | US20000257887P | 21.12.2000 Original published format: US 257887 P | US20010286949P | 27.04.2001 Original published format: US 286949 P | [2010/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2264028 | Date: | 22.12.2010 | Language: | EN | [2010/51] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 17.11.2010 | Classification | IPC: | C07D401/14, C07D403/12, C07D401/12, C07D403/14, C07D405/14, C07D417/14, C07D487/04, C07D491/04, C07D495/04, A61K31/506, A61P35/00 | [2015/09] | CPC: |
C07D403/14 (EP,US);
C07D401/12 (EP,KR,US);
A61P1/00 (EP);
A61P11/06 (EP);
A61P13/12 (EP);
A61P15/00 (EP);
A61P17/06 (EP);
A61P17/14 (EP);
A61P19/02 (EP);
A61P19/08 (EP);
A61P19/10 (EP);
A61P21/00 (EP);
A61P21/02 (EP);
A61P21/04 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/14 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P3/08 (EP);
A61P3/10 (EP);
A61P3/14 (EP);
A61P31/12 (EP);
A61P31/18 (EP);
A61P31/20 (EP);
A61P31/22 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P35/04 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
A61P5/00 (EP);
A61P5/18 (EP);
A61P9/00 (EP);
A61P9/04 (EP);
A61P9/08 (EP);
A61P9/10 (EP);
C07D231/12 (EP,US);
C07D233/56 (EP,US);
C07D249/08 (EP,US);
C07D401/14 (EP,US);
C07D403/12 (EP,US);
C07D405/14 (EP,US);
C07D407/14 (EP,US);
C07D409/14 (EP,US);
C07D417/14 (EP,US);
C07D471/04 (EP,US);
C07D473/16 (EP,US);
C07D487/04 (EP,US);
C07D491/04 (EP,US);
|
Former IPC [2010/51] | C07D403/12, C07D401/14, A61K31/506, A61P35/00 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2010/51] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | Pyrazoleverbindungen als Protein- kinasehemmer | [2010/51] | English: | Pyrazole compounds useful as protein kinase inhibitors | [2010/51] | French: | Composés de pyrazole utiles en tant qu'inhibiteurs de protéine kinase | [2010/51] | Examination procedure | 22.06.2011 | Amendment by applicant (claims and/or description) | 22.06.2011 | Examination requested [2011/31] | 04.12.2012 | Despatch of a communication from the examining division (Time limit: M04) | 10.04.2013 | Reply to a communication from the examining division | 01.07.2013 | Despatch of a communication from the examining division (Time limit: M04) | 25.10.2013 | Reply to a communication from the examining division | 12.11.2013 | Despatch of a communication from the examining division (Time limit: M06) | 22.05.2014 | Reply to a communication from the examining division | 09.02.2015 | Communication of intention to grant the patent | 20.06.2015 | Application deemed to be withdrawn, date of legal effect [2016/01] | 31.07.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2016/01] | Parent application(s) Tooltip | EP01994323.2 / EP1353916 | EP06011799.1 / EP1702920 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010994323) is 29.01.2004 | Fees paid | Renewal fee | 13.01.2011 | Renewal fee patent year 03 | 13.01.2011 | Renewal fee patent year 04 | 13.01.2011 | Renewal fee patent year 05 | 13.01.2011 | Renewal fee patent year 06 | 13.01.2011 | Renewal fee patent year 07 | 13.01.2011 | Renewal fee patent year 08 | 13.01.2011 | Renewal fee patent year 09 | 27.12.2010 | Renewal fee patent year 10 | 27.12.2011 | Renewal fee patent year 11 | 26.12.2012 | Renewal fee patent year 12 | 27.12.2013 | Renewal fee patent year 13 | 19.12.2014 | Renewal fee patent year 14 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Rights in Rem or Legal Means of Execution | ID: | 01 | For: | AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR | Date: | 31.10.2014 | [2014/51] | Documents cited: | Search | [A]WO0021955 (ZENECA LTD [GB], et al) [A] 1,2* examples 16-20 *; | [A]WO0039101 (ASTRAZENECA UK LTD [GB], et al) [A] 1,2 * the whole document * | Examination | WO0160816 | by applicant | US2585906 | WO9965897 | WO0012497 | WO0038675 | - BISCHOFF ET AL., EMBO J., (1998), vol. 17, pages 3052 - 3065 | - SCHUMACHER ET AL., J. CELL BIOL., (1998), vol. 143, pages 1635 - 1646 | - KIMURA ET AL., J. BIOL. CHEM., (1997), vol. 272, pages 13766 - 13771 | - COGHLAN ET AL., CHEMISTRY & BIOLOGY, (2000), vol. 7, pages 793 - 803 | - KIM; KIMMEL, CURR. OPINION GENETICS DEV., (2000), vol. 10, pages 508 - 514 | - HAQ ET AL., J. CELL BIOL., (2000), vol. 151, page 117 | - KLEIN ET AL., PNAS, (1996), vol. 93, pages 8455 - 9 | - CROSS ET AL., BIOCHEM. J., (1994), vol. 303, pages 21 - 26 | - COHEN, BIOCHEM. SOC. TRANS., (1993), vol. 21, pages 555 - 567 | - MASSILLON ET AL., BIOCHEM J., (1994), vol. 299, pages 123 - 128 | - LAVESTONE ET AL., CURRENT BIOLOGY, (1994), vol. 4, pages 1077 - B6 | - BROWNLEES ET AL., NEUROREPORT, (1997), vol. 8, pages 3251 - 55 | - ZHONG ET AL., NATURE, (1998), vol. 395, pages 698 - 702 | - TAKASHIMA ET AL., PNAS, (1993), vol. 90, pages 7789 - 93 | - PEI ET AL., J. NEUROPATHOL. EXP, (1997), vol. 56, pages 70 - 78 | - FISCHER, P.M.; LANE, D.P., CURRENT MEDICINAL CHEMISTRY, (2000), vol. 7, pages 1233 - 1245 | - MANI, S.; WANG, C.; WU, K.; FRANCIS, R.; PESTEL, R., EXP. OPIN. INVEST. DRUGS, (2000), vol. 9, page 1849 | - FRY, D.W.; GARRETT, M.D., "Current Opinion in Oncologic", ENDOCRINE & METABOLIC INVESTIGATIONAL DRUGS, (2000), vol. 2, pages 40 - 59 | - KHWAJA, A., NATURE, (1990), pages 33 - 34 | - ZANG, Q. Y. ET AL., ONCOGENE, (2000), vol. 19 | - KAZUHIKO, N. ET AL., THE JOURNAL OF NEUROSCIENCE, (2000), vol. 20 | - SORIANO, CELL, (1992), vol. 69, page 551 | - SORIANO ET AL., CELL, (1991), vol. 64, page 693 | - TAKAYANAGI, J. CLIN. INVEST., (1999), vol. 104, page 137 | - BOSCHELLI, DRUGS OF THE FUTURE 2000, (2000), vol. 25, no. 7, page 717 | - TALAMONTI, J. CLIN. INVEST., (1993), vol. 91, page 53 | - LUTZ, BIOCHEM. BIOPHYS. RES., (1998), vol. 243, page 503 | - ROSEN, J. BIOL. CHEM., (1986), vol. 261, page 13754 | - BOLEN, PROC. NATL. ACAD. SCI. USA, (1987), vol. 84, page 2251 | - MASAKI, HEPATOLOGY, (1998), vol. 27, page 1257 | - BISCARDI, ADV. CANCER RES., (1999), vol. 76, page 61 | - LYNCH, LEUKEMIA, (1993), vol. 7, page 1416 | - WIENER, CLIN. CANCER RES., (1999), vol. 5, page 2164 | - STALEY, CELL GROWTH DIFF., (1997), vol. 8, page 269 | - MOLINA ET AL., NATURE, (1992), vol. 357, page 161 | - J. INDIAN. CHEM. SOC., (1984), vol. 61, pages 690 - 693 | - J. MED. CHEM., (1994), vol. 37, pages 3828 - 3833 | - BIOORG. MED. CHEM. LETT, (2000), vol. 10, no. 11, pages 1175 - 1180 | - J. HET. CHEM, (1984), vol. 21, pages 1161 - 1167 | - J. MED. CHEM, (1995), vol. 38, no. 14, pages 2763 - 2773 | - CHEM. PHARM. BULL., (1992), vol. 40, no. 1, pages 227 - 229 | - J. HET. CHEM., (1984), vol. 21, pages 1161 - 1167 | - BIOORG. MED. CHEM. LETT, (1998), vol. 8, no. 20, pages 2891 - 2896 | - CHEM. HETEROCYCL. COMPD., (1999), vol. 35, no. 7, pages 818 - 820 | - J. CHEM. SECT. B, (1983), vol. 22, no. 1, pages 37 - 42 | - PESTIC. SCI, (1996), vol. 47, no. 2, pages 103 - 114 | - J. MED. CHEM., (1980), vol. 23, no. 8, pages 913 - 918 | - PHARMAZIE, (1988), vol. 43, no. 7, pages 475 - 476 | - J. MED. CHEM., (2000), vol. 43, no. 22, pages 4288 - 4312 | - J. MED. CHEM., (1998), vol. 41, no. 20, pages 3793 - 3803 | - J. MED. CHEM., (1995), vol. 38, no. 14, pages 2763 - 2773 | - BIOORG. MED. CHEM. LETT., (1997), vol. 7, no. 4, pages 421 - 424 | - BIOORG. MED. CHEM. LETT., (2000), vol. 10, no. 8, pages 703 - 706 | - J. MED. CHEM., (1998), vol. 41, no. 21, pages 4021 - 4035 | - J. AM. CHEM. SOC., (1959), vol. 81, pages 5997 - 6006 | - BIOORG. MED. CHEM. LETT., (2000), vol. 10, no. 8, pages 821 - 826 | - J. MED. CHEM., (1984), vol. 27, no. 12, pages 1621 - 1629 | - INDIAN J. CHEM. SECT. B, (1995), vol. 34, no. 9, pages 778 - 790 | - J. CHEM. SOC., (1947), pages 899 - 905 | - J. CHEM. SOC., (1948), vol. 34, no. 9, pages 777 - 782 | - INDIAN J. CHEM., (1967), pages 467 - 470 | - JEFFERY, J. E. ET AL., J. CHEM SOC, (1996), pages 2583 - 2589 | - GNECCO, D. ET AL., ORG PREP PROCED INT, (1996), vol. 28, no. 4, pages 478 - 480 | - FEDORYNSKI, M.; JONCZYK, A., ORG PREP PROCED INT, (1995), vol. 27, no. 3, pages 355 - 359 | - SUZUKI, S ET AL., CAN J CHEM, (1994), vol. 71, no. 2, pages 357 - 361 | - PRASAD, G. ET AL., J ORG CHEM, (1991), pages 7188 - 7190 | - MOSS, R. ET AL., TETRAHEDRON LETT, (1995), pages 8761 - 8764 | - GARIGIPATI, R., TETRAHEDRON LETT, (1990), pages 1969 - 1972 | - FOX ET AL., PROTEIN SCI., (1998), vol. 7, page 2249 | - FOX ET AL., PROTEIN SCI, (1998), vol. 7, page 2249 |